Hologic inks deal with Google to unite cloud with diagnostics

By LabPulse.com staff writers

February 1, 2021 -- Hologic has announced a collaboration with Google designed to advance the potential of digital diagnostics for cervical cancer screening by making Google Cloud machine-learning algorithms available for Hologic's Genius Digital Diagnostic System.

Genius is a digital cytology platform that combines artificial intelligence (AI) with digital imaging, with the goal of identifying precancerous lesions and cancer cells in women. Google Cloud will provide a cloud-based platform that enables deep-learning analysis of Genius data, while also providing a secure and reliable cloud data architecture, according to Hologic.

The Genius system has the CE Mark for diagnostic use in Europe; it is not yet available for sale in the U.S.

Diagnostics growth drives Hologic's Q1 results higher
Strong growth in its molecular diagnostics business -- with revenues almost tripling due to the COVID-19 pandemic -- helped drive first-quarter preliminary...
Hologic buys Biotheranostics molecular testing firm
Hologic continues to start 2021 with a bang. The company announced on January 5 that it is acquiring Biotheranostics, a developer of molecular tests for...
FDA OK's new claim for Hologic's HIV assay
The U.S. Food and Drug Administration (FDA) has approved Hologic's diagnostic claim for its HIV-1 viral load monitoring assay, the Aptima HIV-1 Quant...
Hologic wins CE Mark for cervical cancer screening system
Hologic has secured the CE Mark for its Genius Digital Diagnostics digital cytology platform for cervical cancer screening. The system combines a new...
Hologic gets CE Mark for breast specimen x-ray system
Hologic has received the CE Mark for its Faxitron Path+ specimen radiography system, which can be used for breast tissue imaging. The system consists...

Copyright © 2021 LabPulse.com

Last Updated bc 2/2/2021 7:37:41 AM